A deadline for the US federal legislature to pass a bill that was expected to remove hemp and low-THC strains of cannabis from the federal list of narcotics lapsed on 30th September, leaving American hemp farmers in regulatory uncertainty.
Language reclassifying all cannabis below a 0.3% dry weight THC threshold, taking it off of the Drug Enforcement Agency (DEA)’s Schedule 1 list, and putting it in the “agricultural commodity” category, was expected to be part of the larger 2018 Farm Bill, the Congressional reformulation of US agriculture policy which happens about every five years.
This definition would have included both high-CBD, low-THC strains of cannabis that can be used to produce CBD as well as strains of the related hemp plant grown for industrial purposes such as fibres and seeds. In turn this would have made the production and export of CBD from low-THC cannabis varieties legal at the federal level.
...
Restricted content. Do you want to read more?
Register
Sign up NOW for 7 days FREE TRIAL and access our briefings section
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
